Distinct profiles of TERT promoter mutations and telomerase expression in head and neck cancer and cervical carcinoma
C Annunziata, F Pezzuto, S Greggi… - … journal of cancer, 2018 - Wiley Online Library
Two recurrent mutations (–124 G> A and− 146 G> A) in the core promoter region of the
human telomerase reverse transcriptase (TERT) gene create consensus binding sites for …
human telomerase reverse transcriptase (TERT) gene create consensus binding sites for …
Value of intraoperative cytological and pathological sentinel lymph node diagnosis in fertility-sparing trachelectomy for early-stage cervical cancer
K Sonoda, H Yahata, K Okugawa, E Kaneki, T Ohgami… - Oncology, 2018 - karger.com
Abstract Background and Objectives: Trachelectomy, a fertility-sparing surgery for early-
stage cervical cancer, can be performed only when there is no extrauterine extension …
stage cervical cancer, can be performed only when there is no extrauterine extension …
[HTML][HTML] Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma
Abstract Human papillomavirus type 16 (HPV16) is the major cause of cervical cancer and of
a fraction of oropharyngeal carcinoma. Few studies compared the viral expression profiles in …
a fraction of oropharyngeal carcinoma. Few studies compared the viral expression profiles in …
Detection of high-risk human papillomavirus DNA in sentinel lymph nodes of patients with cervical cancer
Y Lu, X Xu, XH Nong, DS Yao - Oncology Letters, 2020 - spandidos-publications.com
The aim of the present study was to investigate the expression of human papillomavirus
(HPV) DNA in sentinel lymph nodes (SLN) in patients with early-stage cervical cancer (CC) …
(HPV) DNA in sentinel lymph nodes (SLN) in patients with early-stage cervical cancer (CC) …
A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer
Y Huang, Q He, K Xu, J Zhou, J Yin, F Li… - International Journal of …, 2019 - ijgc.bmj.com
Objective To assess the prognostic value of human papillomavirus (HPV) viral load in locally
advanced cervical carcinoma treated with radical concurrent chemoradiotherapy. Methods …
advanced cervical carcinoma treated with radical concurrent chemoradiotherapy. Methods …
[HTML][HTML] Human papillomavirus status in primary lesions and pelvic lymph nodes and its prognostic value in cervical cancer patients with lymph node metastases
P Chen, W Zhang, D Yang, W Zhang… - Medical Science Monitor …, 2019 - ncbi.nlm.nih.gov
Background The aim of this study was to assess the presence of HPV DNA in cervical
tissues and lymph nodes in patients who have uterine cervical neoplasms with lymphatic …
tissues and lymph nodes in patients who have uterine cervical neoplasms with lymphatic …
[HTML][HTML] Importance of investigating high-risk human papillomavirus in lymph node metastasis of esophageal adenocarcinoma
P Sharma, SD Gautam, S Rajendra - World Journal of …, 2020 - ncbi.nlm.nih.gov
High-risk human papillomavirus has been suggested as a risk factor for esophageal
adenocarcinoma. Tumor human papillomavirus status has been reported to confer a …
adenocarcinoma. Tumor human papillomavirus status has been reported to confer a …
宫颈癌盆腔淋巴结转移生物标志物研究进展.
巨宇叶, 王雪, 陈思璐, 王晓慧 - Journal of International …, 2020 - search.ebscohost.com
区域淋巴结扩散是宫颈癌转移的主要途径, 淋巴结状态已被纳入国际妇产科联盟(FIGO)
最新宫颈癌分期系统. 多项研究表明, 盆腔淋巴结转移是宫颈癌患者的一个独立预后因素 …
最新宫颈癌分期系统. 多项研究表明, 盆腔淋巴结转移是宫颈癌患者的一个独立预后因素 …
HPV16E6 与吲哚胺2, 3-二氧化酶在宫颈病变组织中的表达.
杨琳琳, 尹春梅, 张磊, 王薇, 赵凌锋… - Journal of Kunming …, 2020 - search.ebscohost.com
目的检测高危HPV 感染的正常宫颈组织, 宫颈癌前病变组织, 宫颈癌组织HPV16E6 和IDO
的表达, 分析二者在宫颈病变组织恶化过程中的关系, 探讨其作为宫颈癌肿瘤标志物的可能性 …
的表达, 分析二者在宫颈病变组织恶化过程中的关系, 探讨其作为宫颈癌肿瘤标志物的可能性 …
宫颈癌患者治疗前检测血清HPV16E6 mRNA 和CK19 mRNA 的临床意义.
杨琳琳, 王薇, 张磊, 张红平… - Journal of Kunming …, 2017 - search.ebscohost.com
目的检测宫颈癌患者治疗前外周血HPV16E6m RNA 和CK19m RNA 的表达,
探讨其对宫颈癌的诊断意义及其与临床病理的相关性. 方法对100 例宫颈癌患者行治疗前外周血 …
探讨其对宫颈癌的诊断意义及其与临床病理的相关性. 方法对100 例宫颈癌患者行治疗前外周血 …